Literature DB >> 32530501

Microbiomics, metabolomics, predicted metagenomics and hepatic steatosis in a population-based study of 1355 adults.

Louise Jm Alferink1, Djawad Radjabzadeh2, Nicole S Erler3, Dina Vojinovic4, Carolina Medina-Gomez2, André G Uitterlinden2,4, Robert J de Knegt1, Najaf Amin4, M Arfan Ikram4, Harry LA Janssen5, J C Kiefte-deJong6, Herold J Metselaar1, Cornelia M van Duijn4,7, Robert Kraaij2, Sarwa Darwish Murad1.   

Abstract

BACKGROUND & AIMS: Previous small studies have appraised the gut microbiome (GM) in steatosis, but large-scale studies are lacking. We studied the association of GM diversity and composition, plasma metabolites, predicted functional metagenomics and steatosis. Approach & Results This is a cross-sectional analysis of the prospective population-based Rotterdam Study. We used 16Sribosomal-RNA gene sequencing and determined taxonomy using the Silva-reference database. Alpha-and beta-diversity were calculated using Shannon-index and Bray-Curtis dissimilarities. Differences were tested across steatosis using PerMANOVA. Hepatic steatosis was diagnosed by ultrasonography. We subsequently selected genera using regularized regression. The functional metagenome was predicted based on the GM using KEGG-pathways. Serum metabolomics were assessed using high-throughput proton nuclear magnetic resonance. All analyses were adjusted for age, sex, BMI, alcohol, diet, and proton-pump inhibitors. We included 1355 participants of which 472 had steatosis. Alpha-diversity was lower in steatosis (P=1.1∙10-9 ) and beta-diversity varied across steatosis strata (P=0.001). Lasso selected 37 genera of which three remained significantly associated after adjustment (Coprococcus3: β=-65; Ruminococcus Gauvreauiigroup: β=62; and Ruminococcus Gnavusgroup: β=45, Q-value =0.037). Predicted metagenome analyses revealed that pathways of secondary bile-acid synthesis and biotin metabolism were present and D-alanine metabolism was absent in steatosis. Metabolic profiles showed positive associations for aromatic-and branched chain amino acids and glycoprotein acetyls with steatosis and R. Gnavusgroup, whereas these metabolites were inversely associated with alpha-diversity and Coprococcus3.
CONCLUSIONS: We confirmed, for the first time on a large-scale, the lower microbial diversity and association of Coprococcus and Ruminococcus Gnavus with steatosis. We additionally showed that steatosis and alpha-diversity share -opposite- metabolic profiles. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  gut microbiome; hepatic steatosis; liver stiffness; metabolomics; metagenomics

Year:  2020        PMID: 32530501     DOI: 10.1002/hep.31417

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

Review 1.  Detangling the interrelations between MAFLD, insulin resistance, and key hormones.

Authors:  Shreya C Pal; Mohammed Eslam; Nahum Mendez-Sanchez
Journal:  Hormones (Athens)       Date:  2022-08-03       Impact factor: 3.419

Review 2.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

Review 3.  Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions.

Authors:  Tomas Hrncir; Lucia Hrncirova; Miloslav Kverka; Robert Hromadka; Vladimira Machova; Eva Trckova; Klara Kostovcikova; Pavlina Kralickova; Jan Krejsek; Helena Tlaskalova-Hogenova
Journal:  Microorganisms       Date:  2021-04-29

4.  Berberine Relieves Metabolic Syndrome in Mice by Inhibiting Liver Inflammation Caused by a High-Fat Diet and Potential Association With Gut Microbiota.

Authors:  Jinjin Li; Jialin Li; Jiajia Ni; Caibo Zhang; Jianlei Jia; Guoying Wu; Hongzhao Sun; Shuzhen Wang
Journal:  Front Microbiol       Date:  2022-01-12       Impact factor: 5.640

5.  Associations of the gut microbiome with hepatic adiposity in the Multiethnic Cohort Adiposity Phenotype Study.

Authors:  Meredith A J Hullar; Isaac C Jenkins; Timothy W Randolph; Keith R Curtis; Kristine R Monroe; Thomas Ernst; John A Shepherd; Daniel O Stram; Iona Cheng; Bruce S Kristal; Lynne R Wilkens; Adrian Franke; Loic Le Marchand; Unhee Lim; Johanna W Lampe
Journal:  Gut Microbes       Date:  2021 Jan-Dec

6.  Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease.

Authors:  Bei Gao; Yixin Zhu; Nan Gao; Weishou Shen; Peter Stärkel; Bernd Schnabl
Journal:  Metabolites       Date:  2021-11-10

7.  Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction.

Authors:  Amedeo Lonardo; Ashwani K Singal; Natalia Osna; Kusum K Kharbanda
Journal:  Metab Target Organ Damage       Date:  2022-08-22

8.  Long-term association between diet quality and characteristics of the gut microbiome in the multiethnic cohort study.

Authors:  Erica Ma; Gertraud Maskarinec; Unhee Lim; Carol J Boushey; Lynne R Wilkens; V Wendy Setiawan; Loïc Le Marchand; Timothy W Randolph; Isaac C Jenkins; Keith R Curtis; Johanna W Lampe; Meredith A J Hullar
Journal:  Br J Nutr       Date:  2021-08-09       Impact factor: 4.125

9.  Activation of the gut microbiota-kynurenine-liver axis contributes to the development of nonalcoholic hepatic steatosis in nondiabetic adults.

Authors:  Guoyuan Sui; Lianqun Jia; Dongmei Quan; Na Zhao; Guanlin Yang
Journal:  Aging (Albany NY)       Date:  2021-09-02       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.